Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

LXRX
Lexicon Pharmaceuticals, Inc.
stock NASDAQ

At Close
Jul 10, 2025 3:59:38 PM EDT
1.13USD+5.607%(+0.06)5,253,342
1.12Bid   1.13Ask   0.01Spread
Pre-market
Jul 10, 2025 9:24:30 AM EDT
1.07USD-0.009%(0.00)15,320
After-hours
Jul 10, 2025 4:53:30 PM EDT
1.12USD-0.885%(-0.01)13,586
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
408.58M
Headquarters
TX, USA
Industry
Biotechnology
Next Earnings
Jul 31, 2025 (21d)
Last Split
May 21, 20151for7reverse
Related
BMRNREGNILMNBTXTMOLGNDESPRAERIRAREALBOXLV
LXRX Stats
Avg. Vol. 10 Day
6,617,026
Avg. Vol. 30 Day
4,660,935
Employees
174
Market Cap
408,575,250
Shares Out.
363,178,000
On/Off Exchange
35%/65%
6 Month Beta
0.49
1 Year Beta
0.66
2 Year Beta
0.79
3 Year Beta
0.46
52 Week Low
0.28
52 Week High
2.45
SMA50
0.72
SMA200
0.87
1 Week
+24.86%
1 Month
+60.46%
3 Month
+127.14%
6 Month
+46.83%
1 Year
-30.98%
2 Year
-51.72%
5 Year
-42.01%
Profile
corporate overview lexicon pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. the genome: our source of discovery we have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. we have integrated a series of recombinant dna and chemistry technologies into a systematic drug discovery and development process. our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients. a diverse pipeline of targeted therapies our genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indicatio

LXRX Stock Summary

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock price today is $1.13, and today's volume is 5,253,342. LXRX is up 5.607% today. The 30 day average volume is 4,660,935. LXRX market cap is 408.58M with 363,178,000 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC